ID   1402P
AC   CVCL_WM21
DR   cancercelllines; CVCL_WM21
DR   Cosmic; 852197
DR   IARC_TP53; 20610
DR   Wikidata; Q93298999
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236His (c.706T>C); ClinVar=VCV000216469; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM25 ! 1402R
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
RX   PubMed=15195137; DOI=10.1038/sj.onc.1207780;
RA   Daniotti M., Oggionni M., Ranzani T., Vallacchi V., Campi V.,
RA   Di Stasi D., Della Torre G., Perrone F., Luoni C., Suardi S.,
RA   Frattini M., Pilotti S., Anichini A., Tragni G., Parmiani G.,
RA   Pierotti M.A., Rodolfo M.;
RT   "BRAF alterations are associated with complex mutational profiles in
RT   malignant melanoma.";
RL   Oncogene 23:5968-5977(2004).
//